Patents by Inventor Cecelia C. Yates

Cecelia C. Yates has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8734775
    Abstract: Disclosed are peptides having activity against receptor CXCR3 are disclosed that exhibit activity in preventing the formation of new vessels and activity in mediating the dissociation of newly-formed vessels and resolving of wounds in the later stages of wound healing. Preferred peptides are derived from the ?-helix portion IP-10 (CXCL10) or from IP-9 (CXCL11), are nontoxic, and smaller than naturally occurring peptides, making them useful in therapies against diseases or disease states marked by unwanted angiogenesis, including tumorogenic diseases such as cancers, and in healing of chronic wounds.
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: May 27, 2014
    Assignees: University of Pittsburgh, Tuskegee University
    Inventors: Cecelia C. Yates-Binder, Jesse Jaynes, Timothy Turner, Alan Wells, Richard J. Bodnar
  • Publication number: 20130053319
    Abstract: Disclosed are peptides having activity against receptor CXCR3 are disclosed that exhibit activity in preventing the formation of new vessels and activity in mediating the dissociation of newly-formed vessels and resolving of wounds in the later stages of wound healing. Preferred peptides are derived from the ?-helix portion IP-10 (CXCL10) or from IP-9 (CXCL11), are nontoxic, and smaller than naturally occurring peptides, making them useful in therapies against diseases or disease states marked by unwanted angiogenesis, including tumorogenic diseases such as cancers, and in healing of chronic wounds.
    Type: Application
    Filed: August 26, 2011
    Publication date: February 28, 2013
    Inventors: Cecelia C. Yates-Binder, Jesse Jaynes, Timothy Turner, Alan Wells, Richard J. Bodnar